26U vs NOVN: Side-by-Side Comparison
Compare 26U (26U) and Novartis AG (NOVN) side by side: market cap EUR 127.86M vs CHF 244.54B. Financials, growth and model signals on Bullrun.
| Metric | 26U | NOVN |
|---|---|---|
| Company | 26U | Novartis AG |
| Country / Exchange | Switzerland · F | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - General |
| Market cap | EUR 127.86M | CHF 244.54B |
| P/E ratio | — | 22.7 |
| Dividend yield | — | 2.96% |
| Valuation model | — | 6.8% undervalued |
| Revenue (latest FY) | EUR 10.80M | — |
| Revenue growth YoY | +56.6% | — |
| Net income | EUR -1.42M | — |
| Gross margin | 26.3% | — |
| Diluted EPS | -0.28 | — |